Positive Clinical Outcomes in Two Phase 2a Studies: ADAS-Cog in Alzheimer’s and MDS-UPDRS in Parkinson’s patients plus Markers of Toxic Cascade that Leads to Nerve Cell Death

Posiphen (R-phenserine) - Annovis Bio

Michael Chen; Priscilla Hernandez; Kore Liow; Maria L. Maccecchini; Henrik Zetterberg

Aug 2, 2021